Article EMA Thank You EMA’s 2023 new medicines report suggests return to pre-pandemic volume
Agency IQ
JANUARY 19, 2024
EMA’s 2023 new medicines report suggests return to pre-pandemic volume This week, the EMA released its 2023 New Medicines Highlights report, providing insights into the number of opinions provided and the types of products reviewed. Seventeen products were orphan drugs, fourteen were generics and eight were biosimilars.
Let's personalize your content